Surfactant protein A genetic variants associate with severe respiratory insufficiency in pandemic influenza A virus infection

Critical Care

Volumn 18, Issue 3, 2014, Pages

  Herrera Ramos, Estefanía ^a,b   López Rodríguez, Marta ^a   Ruíz Hernández, José J ^a   Horcajada, Juan P ^c,d   Borderías, Luis ^e   Lerma, Elisabeth ^c   Blanquer, José ^f   Pérez González, María C ^a   García Laorden, María I ^a,g   Florido, Yanira ^a,b   Mas Bosch, Virginia ^h   Montero, Milagro ^c   Ferrer, José M ^a   Sorlí, Luisa ^c   Vilaplana, Carlos ^h   Rajas, Olga ⁱ   Briones, Marisa ^f   Aspa, Javier ⁱ   López Granados, Eduardo ^j   Solé Violán, Jordi ^a   de Castro, Felipe R ^a,b   Rodríguez Gallego, Carlos ^a,b   more..

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^e HOSPITAL SAN JORGE   (Spain)

^f UNIVERSITY OF VALENCIA   (Spain)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h Laboratori de Referencia de Catalunya   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^j HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

SURFACTANT PROTEIN A;

ADULT; BLOOD PRESSURE; FEMALE; GENETICS; HAPLOTYPE; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; MALE; MISSENSE MUTATION; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BLOOD PRESSURE; FEMALE; HAPLOTYPES; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84902745832     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13934     Document Type: Article

References (30)

1. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, Kumar A, Lim M, Shindo N, Penn C, Nicholson KG. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010, 362:1708-1719.
2. Horby P, Nguyen NY, Dunstan SJ, Baillie JK. The role of host genetics in susceptibility to influenza: a systematic review. PLoS One 2012, 7:e33180. 10.1371/journal.pone.0033180, 3305291, 22438897.
3. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA. Evidence for a heritable predisposition to death due to influenza. J Infect Dis 2008, 197:18-24. 10.1086/524064, 18171280.
4. Keynan Y, Malik S, Fowke KR. The role of polymorphisms in host immune genes in determining the severity of respiratory illness caused by pandemic H1N1 influenza. Public Health Genomics 2013, 16:9-16. 10.1159/000345937, 23548712.
5. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005, 5:58-68. 10.1038/nri1528, 15630429.
6. Eisen DP. Mannose-binding lectin deficiency and respiratory tract infection. J Innate Immun 2010, 2:114-122. 10.1159/000228159, 20375630.
7. Ng WC, Tate MD, Brooks AG, Reading PC. Soluble host defense lectins in innate immunity to influenza virus. J Biomed Biotechnol 2012, 2012:732191. 3362216, 22665991.
8. Selman L, Hansen S. Structure and function of collectin liver 1 (CL-L1) and collectin 11 (CL-11, CL-K1). Immunobiology 2012, 217:851-863. 10.1016/j.imbio.2011.12.008, 22475410.
9. Hawgood S, Brown C, Edmondson J, Stumbaugh A, Allen L, Goerke J, Clark H, Poulain F. Pulmonary collectins modulate strain-specific influenza a virus infection and host responses. J Virol 2004, 78:8565-8572. 10.1128/JVI.78.16.8565-8572.2004, 479098, 15280465.
10. LeVine AM, Hartshorn K, Elliott J, Whitsett J, Korfhagen T. Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection. Am J Physiol Lung Cell Mol Physiol 2002, 282:L563-L572.
11. Li G, Siddiqui J, Hendry M, Akiyama J, Edmondson J, Brown C, Allen L, Levitt S, Poulain F, Hawgood S. Surfactant protein-A-deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus. Am J Respir Cell Mol Biol 2002, 26:277-282. 10.1165/ajrcmb.26.3.4584, 11867335.
12. Hartshorn KL, White MR, Shepherd V, Reid K, Jensenius JC, Crouch EC. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am J Physiol 1997, 273:L1156-L1166.
13. Job ER, Deng YM, Tate MD, Bottazzi B, Crouch EC, Dean MM, Mantovani A, Brooks AG, Reading PC. Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J Immunol 2010, 185:4284-4291. 10.4049/jimmunol.1001613, 20817882.
14. Mikerov AN, White M, Hartshorn K, Wang G, Floros J. Inhibition of hemagglutination activity of influenza A viruses by SP-A1 and SP-A2 variants expressed in CHO cells. Med Microbiol Immunol 2008, 197:9-12. 2917902, 17520282.
15. Silveyra P, Floros J. Genetic variant associations of human SP-A and SP-D with acute and chronic lung injury. Front Biosci 2012, 17:407-429.
16. Haczku A. Protective role of the lung collectins surfactant protein A and surfactant protein D in airway inflammation. J Allergy Clin Immunol 2008, 122:861-879. 10.1016/j.jaci.2008.10.014, 19000577.
17. Hoover RR, Floros J. Organization of the human SP-A and SP-D loci at 10q22-q23: physical and radiation hybrid mapping reveal gene order and orientation. Am J Respir Cell Mol Biol 1998, 18:353-362. 10.1165/ajrcmb.18.3.3035, 9490653.
18. Garcia-Laorden MI, de Rodriguez CF, Sole-Violan J, Rajas O, Blanquer J, Borderias L, Aspa J, Briones ML, Saavedra P, Marcos-Ramos JA, González-Quevedo N, Sologuren I, Herrera-Ramos E, Ferrer JM, Rello J, Rodríguez-Gallego C. Influence of genetic variability at the surfactant proteins A and D in community-acquired pneumonia: a prospective, observational, genetic study. Crit Care 2011, 15:R57. 10.1186/cc10030, 3221990, 21310059.
19. Garcia-Laorden MI, de Rodriguez CF, Sole-Violan J, Payeras A, Briones ML, Borderias L, Aspa J, Blanquer J, Rajas O, Marcos-Ramos JA, Herrera-Ramos E, García-Bello MA, Noda J, Ferrer JM, Rello J, Rodríguez-Gallego C. The role of mannose-binding lectin in pneumococcal infection. Eur Respir J 2013, 41:131-139. 10.1183/09031936.00174111, 22523362.
20. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: The ACCP/SCCM Consensus Conference Committee, American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
21. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R, . The American-European Consensus Conference on ARDS Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824. 10.1164/ajrccm.149.3.7509706, 7509706, The American-European Consensus Conference on ARDS.
22. DiAngelo S, Lin Z, Wang G, Phillips S, Ramet M, Luo J, Floros J. Novel, non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles. Dis Markers 1999, 15:269-281. 10.1155/1999/961430, 3851098, 10689550.
23. The International HapMap Consortium A haplotype map of the human genome. Nature 2005, 437:1299-1320. 10.1038/nature04226, 1880871, 16255080, The International HapMap Consortium.
24. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265. 10.1093/bioinformatics/bth457, 15297300.
25. Foreman MG, Kong X, DeMeo DL, Pillai SG, Hersh CP, Bakke P, Gulsvik A, Lomas DA, Litonjua AA, Shapiro SD, Tal-Singer R, Silverman EK. Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2011, 44:316-322. 10.1165/rcmb.2009-0360OC, 3095932, 20448057.
26. Lingappa JR, Dumitrescu L, Zimmer SM, Lynfield R, McNicholl JM, Messonnier NE, Whitney CG, Crawford DC. Identifying host genetic risk factors in the context of public health surveillance for invasive pneumococcal disease. PLoS One 2011, 6:e23413. 10.1371/journal.pone.0023413, 3156135, 21858107.
27. Job ER, Deng YM, Barfod KK, Tate MD, Caldwell N, Reddiex S, Maurer-Stroh S, Brooks AG, Reading PC. Addition of glycosylation to influenza A virus hemagglutinin modulates antibody-mediated recognition of H1N1 2009 pandemic viruses. J Immunol 2013, 190:2169-2177. 10.4049/jimmunol.1202433, 23365085.
28. Wang G, Umstead TM, Phelps DS, Al-Mondhiry H, Floros J. The effect of ozone exposure on the ability of human surfactant protein a variants to stimulate cytokine production. Environ Health Perspect 2002, 110:79-84. 1240696, 11781168.
29. Mikerov AN, Umstead TM, Gan X, Huang W, Guo X, Wang G, Phelps DS, Floros J. Impact of ozone exposure on the phagocytic activity of human surfactant protein A (SP-A) and SP-A variants. Am J Physiol Lung Cell Mol Physiol 2008, 294:L121-L130. 2964667, 17981957.
30. Sato A, Whitsett JA, Scheule RK, Ikegami M. Surfactant protein-d inhibits lung inflammation caused by ventilation in premature newborn lambs. Am J Respir Crit Care Med 2010, 181:1098-1105. 10.1164/rccm.200912-1818OC, 2874451, 20133924.